找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Dosing in Obesity; Volume I: Antimicrob Syed Tabish R. Zaidi,Jason A. Roberts Book 2016 Springer International Publishing Switzerland

[復(fù)制鏈接]
樓主: 劉興旺
11#
發(fā)表于 2025-3-23 11:50:53 | 只看該作者
12#
發(fā)表于 2025-3-23 15:43:04 | 只看該作者
13#
發(fā)表于 2025-3-23 21:23:30 | 只看該作者
D. Creel,H. Spekreijse,D. Reitsaspofungin and micafungin. They have broad spectrum activity against the majority of . and . species and consensus guidelines recommend echinocandins for the treatment of invasive candidiasis, for salvage therapy for invasive aspergillosis and for prophylaxis for invasive candidiasis in select high
14#
發(fā)表于 2025-3-23 22:56:09 | 只看該作者
15#
發(fā)表于 2025-3-24 03:35:46 | 只看該作者
Observations of Faint Globular Clustersmation on the pharmacokinetics (PK) variability or dosing strategies for obese patients. This chapter will briefly outline the literature and dosing recommendations for other miscellaneous antimicrobials that are not presented elsewhere in this book. Dosing recommendations for these agents in obese
16#
發(fā)表于 2025-3-24 07:17:30 | 只看該作者
Book 2016written by a group of doctors and pharmacists working in infectious diseases practice and research...The introductory chapter outlines the important physiological changes in obesity including factors affecting the dosing of antimicrobials in obese patients. The introductory chapter is followed by te
17#
發(fā)表于 2025-3-24 13:23:36 | 只看該作者
M. A. Beran,F. Alayne Street-Perrottstanding of the focus of infection, relative susceptibilities of the micro-organism involved, the best match of the body size descriptor for the antimicrobial in question and the renal function of the patients under treatment.
18#
發(fā)表于 2025-3-24 15:37:35 | 只看該作者
H. M. Dekhuijzen,D. R. Verkerke,A. Houwerse significant dose related adverse effects and therefore, the clinical need of a flouroquinolone should be carefully considered before using them in obese patients, who are likely to receive higher than the usually recommended doses.
19#
發(fā)表于 2025-3-24 21:13:56 | 只看該作者
20#
發(fā)表于 2025-3-25 01:55:38 | 只看該作者
Introduction,standing of the focus of infection, relative susceptibilities of the micro-organism involved, the best match of the body size descriptor for the antimicrobial in question and the renal function of the patients under treatment.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-31 21:57
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
廊坊市| 大埔区| 忻城县| 抚顺市| 淳化县| 柘城县| 清苑县| 楚雄市| 锦屏县| 抚远县| 鲁甸县| 定南县| 达日县| 固始县| 曲水县| 寿阳县| 湘潭县| 东城区| 平乐县| 东乡族自治县| 六安市| 连山| 丹东市| 博野县| 铜鼓县| 防城港市| 红桥区| 从化市| 商洛市| 屏东县| 滦平县| 贵州省| 玛曲县| 西林县| 浙江省| 安陆市| 营山县| 澄江县| 贵阳市| 宝丰县| 武鸣县|